Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV000770436 | SCV000901879 | uncertain significance | Cardiomyopathy | 2015-11-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001435845 | SCV001638674 | likely benign | Hypertrophic cardiomyopathy 14 | 2024-04-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004024142 | SCV005018938 | likely benign | Cardiovascular phenotype | 2023-12-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000556217 | SCV001951447 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000556217 | SCV001966414 | likely benign | not provided | no assertion criteria provided | clinical testing |